Dr. Reddy's Labs Files Routine 6-K Disclosure
Ticker: RDY · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, routine-disclosure
Related Tickers: RDY
TL;DR
DRL filed a 6-K, just a routine check-in, no big news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on June 11, 2025, to report its status as a foreign private issuer. The company, headquartered in Hyderabad, India, is required to file annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates but serves as a routine disclosure.
Why It Matters
This filing is a standard procedural document for foreign private issuers, indicating ongoing compliance with SEC reporting requirements. It does not signal new business developments or financial performance.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain material non-public information.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-25-000402 (accession_number) — Filing identifier
- June 11, 2025 (date) — Filing date
- Hyderabad, India (location) — Company headquarters
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report information required by Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 by a foreign private issuer, specifically Dr. Reddy's Laboratories Ltd.
When was this Form 6-K filed?
This Form 6-K was filed on June 11, 2025.
What is the principal executive office address of Dr. Reddy's Laboratories Ltd.?
The principal executive office address is 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or Form 40-F?
Dr. Reddy's Laboratories Ltd. indicates that it files annual reports under cover of Form 20-F.
Is this filing submitted in paper format?
The filing does not explicitly state it is submitted in paper, and it notes that Regulation S-T Rule 101(b)(1) only permits paper submission of a Form 6-K under specific circumstances, which are not detailed here.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding DR REDDYS LABORATORIES LTD (RDY).